Welcome to BrainSee
The first and only FDA-approved technology to guide prognosis in people with memory concerns or mild cognitive impairment (MCI)
On the next few pages, you will be asked to confirm your contact information.
Together we prevent and postpone dementia
Televisit
Comprehensive memory tests
MRI
Near your home
Care plan
Stay healthy & reduce risk
Listen to Dr. Vejdani discussing the necessity of BrainSee for MCI patients
Get your BrainSee test today
Forgetfulness is not always because of Alzheimer’s disease (AD). Half of patients diagnosed with mild cognitive impairment (MCI) never progress to dementia in their lifetime. With the help of BrainSee, the first FDA-approved prognostic tool, doctors can now determine how likely an MCI patient is to remain stable (or even improve) or progress to AD-dementia in the next 5 years.
Low risk
- Reassurance and avoid invasive
- Alzheimer tests and drugs
High risk
- Early treatments, life & care planning, monitoring
- Prevent / delay dementia
What is BrainSee?
BrainSee is a medical software designed to help physicians determine the prognosis of patients who have amnestic mild cognitive impairment (aMCI).
BrainSee’s novel medical AI algorithm processes a patient’s MRI and cognitive scores and provides a score between 0 and 100 (lower is better) that helps doctors determine the patient’s likelihood of progression from mild cognitive impairment to Alzheimer’s dementia.
Why use BrainSee instead of (or before) PET or CSF biomarkers?
Users: Medical Doctors
BrainSee is essential for any clinician who evaluates patients with mild cognitive impairment. These clinicians generally include geriatricians, neurologists, psychiatrists, family physicians, and primary care physicians.
Benefits of BrainSee
01
BrainSee is a medical software designed to help physicians determine the prognosis of patients who have amnestic mild cognitive impairment (aMCI).
02
BrainSee is a medical software designed to help physicians determine the prognosis of patients who have amnestic mild cognitive impairment (aMCI).
03
BrainSee is a medical software designed to help physicians determine the prognosis of patients who have amnestic mild cognitive impairment (aMCI).
Inputs:
- Brain MRI (standard 3D T1, no contrast injection, no radiation)
- Cognitive test scores (MMSE & CDRSB)
Note: BrainSee inputs are part of current clinical workup of mild cognitive impairment patients. No extra burden.
Output:
A printable report that provides a prognostic score and instructions on how to interpret it.
Why BrainSee?
Non-invasive
No injection or radiation
Most accurate
90% accuracy (next best: 70%)
Convenient
Affordable and globally available
Book an appointment
Our doctor will perform an initial cognitive assessment and order a brain MRI scan for you. S’he will then run the BrainSee AI analysis and provide personalized recommendations and care plan. You can also join our comprehensive cognitive management program to prevent and postpone dementia.
Real Stories, Real Results
"The relief was immediate and profound. When my BrainSee test came back with a low-risk score, it felt like a big weight was lifted off my entire family’s shoulders. We had been constantly worrying and thinking about moving me to an assisted living facility due to my frequent memory slips. Now, those plans are replaced by more family gatherings at my home, where I feel happiest. It’s amazing how one simple and accurate test can change the family dynamics and restore peace and enjoyment in our lives. I strongly recommend BrainSee to all my family and friends."
"The moment I was told I was at risk for Alzheimer’s, a flurry of fears raced through my mind—fears of dependency, of forgetting my loved ones, of losing myself. But the beauty of the BrainSee score is that it doesn’t spell the end; it’s actually an early warning to change something in my life and benefit from Alzheimer’s treatments most of which are more effective if taken early during the disease process. My BrainSee score was the beginning of a carefully managed approach to my health, thanks to the team of BrainSee doctors. I was given a comprehensive treatment plan and Medicare paid for it. I also signed up for a lifestyle management program by Darmiyan. Over the past several months, I’ve seen my risk profile decrease dramatically, which is beyond empowering. I can’t explain how I and my family feel about the new hope."
"I’ve always cherished my independence, so when relatives started hinting at needing more intensive care for me, I was very upset. No one in my immediate family has had Alzheimer’s. Taking the BrainSee test was my way of showing them—and convincing myself—that I was still capable of handling my day-to-day life. I heard that even if I turned out to be at high risk, there was still a lot I could do to reduce my risk and postpone dementia. My doctor recommended that I repeat the test next year to make sure all the right things I’m doing are actually effective. The BrainSee results gave us all a sigh of relief. Now, I continue to lead a fulfilling life, contributing my time as a part-time teacher and volunteer at our community library. It’s empowering and satisfying to know that my mental faculties are still sharp."
"Receiving a low risk for AD allowed me to avoid the unnecessary and invasive tests some of my friends had endured. I’m focusing on maintaining a healthy lifestyle and staying active in my community, knowing that my cognitive health is in my hands. BrainSee test was easy to do and their doctors are the best."
"After a misdiagnosis of depression and being on annoying antidepressants for almost 7 years, I heard about BrainSee that is FDA-approved and a breakthrough for mild cognitive impairment. Luckily my psychiatrist was already a part of their network and prescribed the test for me. I had already gotten a brain MRI scan a month earlier, and my doctor had done my memory tests in the office, so there was nothing else for me to do. The BrainSee analysis showed that I’m at high risk for Alzheimer’s, unless I did something different. My psychiatrist immediately changed my treatment plan and referred me to a neurologist. I’m not happy to be at high risk, but I’m glad the misdiagnosis was corrected. Antidepressants had only worsened my life for several years. Clarity is always good and puts one on the right track. Thanks to the BrainSee test my family is now more caring and actively helping me reduce my risk of developing dementia."
"Finding out that I was low-risk for Alzheimer’s disease with the BrainSee test wasn’t just good news, it was liberating. I had feared the possibility of heavy medications and their side effects especially these new ones with mediocre efficacy. Now, free from that worry, I have a more natural lifestyle that integrates herbal remedies and mental exercises into my daily routine. It’s refreshing to live my golden years without the cloud of medications hanging over me. I can now enjoy every day to its fullest with friends and family. The BrianSee test is a fully non-invasive screening that every patient with memory concerns needs to do. My wife is scheduled to do the test as well."
"Alzheimer’s runs in our family. I’ve seen that the moment dementia hits you it’s too late to do anything meaningful. Being prognosed as high-risk with BrainSee test was initially upsetting – although expected – but it quickly turned into an opportunity for proactive planning. With clarity about my condition, I was able to make informed decisions and focus on what was truly important: my health and spending quality time with my friends. I’ve been planning to travel the world and die somewhere in the middle of a forest or the height of a mountain. My doctor said my treatment plan is tailored to my specific needs, considering my cardiovascular issues and high blood pressure. My treatment is helping optimize my cognition and let me lead an active and independent life. My doctor even allowed me to travel as long as I retake the BrainSee test in 6 months to show him how impactful traveling has been on my cognitive health. I’ve become an advocate for BrainSee, sharing my story with others to emphasize the critical nature of understanding one’s cognitive health early."
"Learning I was at high risk for Alzheimer’s was a pivotal moment in my life. It spurred me into action, reevaluating my health, my philosophy of life and my entire future. I’m still young and can do better than this. I changed my diet and included more fresh fruits and vegetables and increased my exercise activities. My doctor adjusted my blood pressure and diabetes medications, and I’m already seeing a huge change in my memory and daily cognitive functions. The new medications have been life-changing, maybe because I have signed up for a healthy lifestyle as well. Under the guidance of my BrainSee doctor, I’m monitoring my progress. I have done the BrainSee test twice so far and got a better score the second time around, which shows improvement in my condition according to my doctor. This journey for me is about preserving my mind, improving my overall quality of life, and proving that with the right support and early action, the tide can be turned against Alzheimer’s."
"Concerned about my family history of Alzheimer’s, I took the BrainSee test twice (within 4 months). Thankfully, my low-risk score has kept me away from unnecessary amyloid PET scans, saving me from discomfort, hassle, and hefty bills. I still have my memory concerns but through BrainSee network I’ve got to know several excellent wellness solutions that have totally changed my life."
"When my relatives began to question my cognitive health and eye my assets, the BrainSee test came to my rescue by confirming a low risk of Alzheimer’s. Now, I continue to manage my estate and finances with full confidence and autonomy. I can live an independent life happily and take care of myself and my house. My two cents: get your BrainSee test done before it’s too late."
"I was so afraid that my forgetfulness would be an early sign of Alzheimer's. I’d lost freedom to live as I wanted to and thought that dementia would soon hold me back. With a simple BrainSee analysis, I found those fears melting away. My cognitive function didn’t control me – I controlled it."